Caladrius Biosciences
Posted on: March 20, 2017
By: Kim Berlowitz
With: Comments Off on Caladrius Biosciences
Exclusive financial advisor to Caladrius Biosciences on the sale of its remaining 80.1% equity stake in its PCT, LLC subsidiary